ARS Pharmaceuticals Inc (NASDAQ:SPRY)
| 6.33 Delayed Data As of Jan 30 |  +0.01 / +0.16%Today’s Change | 2.80 Today|||52-Week Range 9.17 | -25.79% Year-to-Date |
Latest SPRY News | Press Releases
No recent news for ARS Pharmaceuticals Inc.
Today’s Trading
| Previous close | 6.32 |
| Today’s open | 6.15 |
| Day’s range | 6.00 - 6.37 |
| Volume | 7,146 |
| Average volume (3 months) | 217,846 |
| Market cap | $603.1M |
Data as of 4:00pm ET, 01/30/2023
Growth & Valuation
| Earnings growth (last year) | -169.84% |
| Earnings growth (this year) | +80.94% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.71 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | March 29, 2023 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$89.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
